Skin research sees Beiersdorf utilize active to treat pigmentation in new skin care range
The company’s skin research center in Hamburg, Germany, investigated problems associated with hyper-pigmentation testing B-Resorcinol; which following convincing results, will be the active used in Eucerin’s latest Even Brighter Clinical range.
Many women suffer from pigmentation disorders, and these can have different causes and are also intensified by UV radiation; something Beiersdorf claims led to the research.
Consumer needs
"The new products were developed especially for the needs of our consumers. About one in every three women over 40 suffers from hyper-pigmentation, including younger women who are increasingly affected as well. Until now there was no easy answer to this problem," says Dilara Dzafik, international brand manager Eucerin Face Care.
"Even Brighter has been clinically tested and starts transforming the complexion into a more even and brighter one after just four weeks of usage.”
In order to get to develop its latest range in-line with demand, the Beiersdorf scientists studied the root of the problem; melanin synthesis.
Source of the problem
When too much melanin is created locally, spots and brown patches of various shapes and sizes form on the skin.
"These collections of melanin are either hereditary, e.g. birth marks, or the result of oxidative reactions through UV light, hormones or inflammation processes in the skin. But the natural aging process and simple moisture loss can also bring the melanocytes out of balance," says Kerstin Bohnsack, senior manager Scientific Endorsement at Beiersdorf.
According to the cosmetics maker, the active ingredient B-Resorcinol works on the source of the problem by preventing the amino acid tyrosine in melanin from being converted limiting the production of melanin.
Those tending to develop pigmented moles not only have to protect their skin with high SPF sun block on sunny days, also every other day too. Even when the sun’s warmth is not felt, melanin production can still be activated, the company's research team observed.
